Abstract:Background: The ε2, ε3 and ε4 alleles of apolipoprotein (APO) E gene constitute a common polymorphism in most populations, among which the APOEε4 allele is known to increase both the susceptibility and severity of Alzheimer's Disease (AD), and it is also associated with lipid profiles. High serum total cholesterol (TC) level in middle age has been proven to be a risk factor for AD and its related pathology. In addition, sex may alter the risk associated with the APOEε4 allele, and gender-specific APOE gene interactions can alter the response to anticholinesterase therapy. Therefore, sex is an important factor in studying the relationship between the APOE gene, lipid profiles and AD, and the underlying mechanism. However, there are few studies on whether there are differences in the effects of APOEε2 and APOEε4 on AD patients and healthy people of different genders, respectively.Material and methods: A total of 549 participants, including 298 AD patients and 251 body mass index (BMI)-matched health controls (HCs), were enrolled. Lipid profiles and APOE genes in both AD patients and matched controls were determined. The cognitive functions of the AD patients were evaluated using the Mini-mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA).Results: (1) The levels of TC and LDL in the AD group were higher than those in HCs. Subgroup analysis found that the AD patients with the APOEε4 allele had higher levels of TC and LDL than HCs carrying the APOEε4 allele, while in individuals without the APOEε4 allele. There was no significant difference in TG and HDL levels between the AD group and HCs. (2) The levels of TC and LDL in the APOEε4 carriers were higher than those in non-APOEε4 carriers. Subgroup analysis found that the increase of TC and LDL in the APOEε4 carriers was found in the AD and female populations, but not in HCs and male populations. (3) The levels of TC and LDL in the APOEε2 carriers were lower than those in non-APOEε2 carriers. Subgroup analysis found that the TC of APOEε2 carriers was lower than that of non-carriers in the male AD population, but not in the female AD population, female HCs, and male HCs. (4) The levels of TC, HDL and LDL in the female population were higher than the male population. (5) The increased LDL level may increase the risk of AD in female people carrying APOEε4.Conclusion: AD patients had higher TC and LDL levels than HCs, especially in the population with the APOEε4 allele. The levels of TC and LDL in the APOEε4 carriers were higher than those in non-APOEε4 carriers, especially in the female AD populations. The TC of APOEε2 carriers was lower than that of non-carriers, especially in male AD populations.

Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations

Effects of human apolipoprotein E isoforms on the amyloid β‐protein concentration and lipid composition in brain low‐density membrane domains

Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer's disease

Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer?s disease

Alzheimer's disease, beta-amyloid protein and zinc.

Apolipoprotein E Lipoprotein Particles Inhibit Amyloid-Β Uptake Through Cell Surface Heparan Sulphate Proteoglycan.

Targeting of Nonlipidated, Aggregated Apoe with Antibodies Inhibits Amyloid Accumulation

AÃÂ² Metabolism and the Role of APOE in AlzheimerÃ¢ÂÂs Disease

Effects of Apolipoprotein E Gene and Sex On Serum Lipid Profiles in Alzheimer's Disease

ApoE and Aβ in Alzheimer's Disease: Accidental Encounters or Partners?

A Novel Apolipoprotein E Antagonist Functionally Blocks Apolipoprotein E Interaction with N-terminal Amyloid Precursor Protein, Reduces Β-Amyloid-associated Pathology, and Improves Cognition

Real-Time Analysis of Specific Binding between Apolipoprotein E Isoforms and Amyloid β-Peptide by Dual Polarization Interferometry

Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides: Identification of an Attomolar-Affinity Copper Binding Site on Amyloid β1-42

Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer’s Disease Spectrum

Differential Regulation of Amyloid-β Endocytic Trafficking and Lysosomal Degradation by Apolipoprotein E Isoforms

P4-188: apolipoprotein e ε4 allele is associated with plasma amyloid beta transport: a population-based cross-sectional study

Cu2+ Affects Amyloid-\b{eta} (1-42) Aggregation by Increasing Peptide-Peptide Binding Forces

Copper Levels Are Increased in the Cerebral Cortex and Liver of APP and APLP2 Knockout Mice

Apolipoprotein E potently inhibits ferroptosis by blocking ferritinophagy

Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides.